期刊文献+

喀什地区2家医院常用镇静催眠药应用分析 被引量:1

Analysis of the Application of Commonly Used Sedative Hypnotic Drug of Two Hospitals in Kashgar District
原文传递
导出
摘要 目的:调查分析喀什地区2家医院精神障碍患者镇静催眠药的应用情况,促进临床合理用药。方法:调取喀什地区2家医院计算机数据库中2010-2012年有关镇静催眠药的处方,对其品种、销售金额、用量、用药天数等进行统计、分析。结果:镇静催眠药销售金额逐年增加,2012年的增长率为23.63%;氟硝西泮销售金额排序居前列,且增幅最大;使用金额分列第2、3位的为阿普唑仑、劳拉西泮;中成药中,天王补心丸的销售金额逐年增加;用药频度(DDDs)排序前5位的为阿普唑仑、氟硝西泮、艾司唑仑、劳拉西泮、地西泮,除阿普唑仑[药物利用指数(DUI)=1.04]外其余药物DUI均<1。结论:喀什地区镇静催眠药使用较多的均为国家基本药物,临床应用较为合理,但加强管理仍十分必要。 OBJECTIVE: To investigate and analyze the application of commonly used sedative hypnotic drug in mental disorder patients from two hospitals in Kashagar district, and to promote rational drug use in the clinic. METHODS: The prescription of sedative hynotic drugs from computer data base of 2 hospitals in Kashagar district in 2010--2012 was analyzed retrospectively. The application categories, sales amount, quantity, drug using days of sedative hypnotic drugs were analyzed statistically. RESULTS: The consumption sum of sedative hypnotic drugs increased year by year with the growth rate of 23.63% in 2012. The consumption sum of flunitrazepam took up the first place with the largest growth, followed by alprazolam and lorazepam. Among Chinese patent medi- cine, the consumption sum of Tianwang buxin pills increased year by year. Top 5 sedative hypnotic drugs in the list of DDDs were alprazolam, flunitrazepam, estazolam, lorazepam and diazepam. Expect alprazolam (DUI= 1.04), the drug utilization index (DUI) of other drugs was less than 1. CONCLUSIONS: Most of sedative hypnotic drugs used in Kashgar district are national essential med- icines, and the application of them is basically rational; it is necessary to strengthen the management of them.
作者 肖卉 任秀云
出处 《中国药房》 CAS CSCD 2014年第34期3189-3191,共3页 China Pharmacy
关键词 精神障碍 镇静催眠 西药 中成药 用药分析 Mental disorder Sedative and hypnotic Western medicine Chinese patent medicine Analysis of drug use
  • 相关文献

参考文献10

二级参考文献70

共引文献66

同被引文献14

  • 1陈清霞,刘伟忠.镇静催眠药的发展状况及其合理用药的必要性[J].医药前沿,2013,3(14):80-81.
  • 2Soldatos CR, Allaert FA, Ohta T, et al. How do individuals sleep around the world.'? Results from a single-day survey in ten countries [ J]. Sleep ned,2005,6 ( 1 ) :5-13.
  • 3Siriwardena AN, Qureshi MZ, Dyas JV, et al. Magic bullets for insomnia? Patients' use and experiences of newer(Z drugs)versus older(benzodiazepine) hypnotics for sleep problems in primary care [J]. Br J Gen Pract,2008,58(551 ) :417-422.
  • 4Walsh JK, Krystal AD, Amato DA, et al. Nightly treatment of primary insomnia with eszopiclone for six months : effect on sleep, quality of life, and work limitations [ J ]. Sleep,2007,30 ( 8 ) :959-968.
  • 5Roth T, Walsh JK, Krystal A, et al. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia[ J]. Sleep Med ,2005,6 ( 6 ) :487-495.
  • 6卫生部.关于印发《精神药品临床应用指导原则》的通知[s].卫医发[2007]39号.2007-01—25.
  • 7廖庆权,陈彩云,朱军,梁丹.我院第二类精神药品处方的调查分析[J].海峡药学,2008,20(5):117-118. 被引量:10
  • 8闫庆松,杨悦.药物利用研究在基本药物制度实施中的应用[J].中国药房,2010,21(4):318-320. 被引量:19
  • 9张薇.以限定日剂量值为基础进行药物利用研究的影响因素分析[J].中国全科医学,2010,13(25):2892-2894. 被引量:80
  • 10李艳,丁庆明.限定日剂量在药物利用研究中的应用[J].中国执业药师,2010,7(9):6-8. 被引量:89

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部